Axogen, Inc. — Director's Dealing 2012

Feb 13, 2012

SEC Form 4/A — Form 4/A

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-10-10

Reporting Person: Mandato Joseph M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-10	Common Stock	A	5455	$2.75	Acquired	1431847	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-10	Stock Option	$2.75	A	12000	Acquired	2018-10-10	Common Stock (12000)	Indirect

Footnotes

F1: These shares were granted in lieu of cash payment to De Novo Ventures II, L.P. ("De Novo"), as compensation for Mr. Mandato's service as a non-employee director through December 31, 2012.

F2: The shares are owned by De Novo. De Novo Management II, LLC is the sole general partner of De Novo. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F3: The options were granted to De Novo as compensation to Mr. Mandato for service on the board of directors. All options vested on the date of grant.